Current management of severe acquired aplastic anemia
Overall survival in severe aplastic anemia has markedly improved in the past four decades due to advances in stem cell transplantation, immunosuppressive therapies and supportive care. Horse anti-thymocyte globulin plus cyclosporine is the standard immunosuppressive regimen in severe aplastic anemia...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2011-06-01
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200229&tlng=en |